Home

malariae

Plasmodium malariae, commonly referred to as malariae, is one of the protozoan parasites that cause malaria in humans. It is transmitted by Anopheles mosquitoes and is associated with a quartan fever pattern, with fever spikes occurring approximately every 72 hours. Compared with the more common P. falciparum and P. vivax, P. malariae tends to produce lower levels of parasitemia and can be more challenging to detect in some settings.

Life cycle and pathology

Sporozoites injected by a mosquito infect liver cells, but unlike some other species, P. malariae does not

Clinical features

Infection produces regular fevers with a 72-hour cycle, along with malaise, anemia, and possible splenomegaly. Complications

Diagnosis and treatment

Diagnosis relies on microscopy of Giemsa-stained blood smears, with band-form trophozoites and rosette schizonts aids in

Epidemiology

P. malariae is found in tropical and subtropical regions, with varying prevalence and often coexisting with

form
hypnozoites
in
the
liver.
After
hepatic
stages,
merozoites
enter
red
blood
cells
and
develop
through
ring,
trophozoite,
and
schizont
stages.
The
trophozoite
stage
often
appears
as
a
distinctive
band
form
across
the
red
cell.
Mature
schizonts
typically
yield
6–12
merozoites
and
can
be
seen
in
thin
blood
films.
Infected
red
cells
are
usually
not
enlarged.
Gametocytes
develop
for
transmission
to
mosquitoes.
The
parasite
can
persist
at
low
levels
for
years
and
may
recrudesce
after
many
months
or
years,
even
without
re-exposure.
can
include
nephrotic
syndrome
and
other
immune-mediated
phenomena,
particularly
with
chronic
infection.
Severe
disease
is
less
common
than
with
P.
falciparum
but
can
occur,
especially
in
young
children
or
individuals
with
limited
immunity.
identification.
Rapid
diagnostic
tests
may
be
less
sensitive
for
P.
malariae
compared
with
other
species;
molecular
methods
(PCR)
can
confirm
diagnosis.
Treatment
has
traditionally
relied
on
chloroquine
in
areas
where
the
parasite
remains
susceptible.
In
regions
with
resistance,
artemisinin-based
combination
therapies
are
used.
Because
P.
malariae
does
not
form
hypnozoites,
primaquine
is
not
required
for
radical
cure.
Prevention
focuses
on
vector
control
and
prophylaxis
tailored
to
local
drug
resistance
patterns.
other
Plasmodium
species.
Surveillance
and
region-specific
treatment
guidelines
guide
management
and
prevention
efforts.